JZJ Chain Drugstore Corporation. Class A

JZJ Chain Drugstore Corporation. Class A

SSSE:605266
13.13
CNY
-0.16
(-1.20%)
-1.42EPS
2.48BMarket Cap
Apr 29Next Earn

Total Valuation

CNY

As of September 30, 2026, JZJ Chain Drugstore Corporation. Class A carries a market capitalization of 2.48B, placing it among publicly traded companies globally. Its enterprise value stands at 5.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.48B
Enterprise Value5.90B

Important Dates

JZJ Chain Drugstore Corporation. Class A's next confirmed earnings release is scheduled for April 29, 2027.

Earnings Date4/29/2027

Share Statistics

As of September 30, 2026, JZJ Chain Drugstore Corporation. Class A has 154.54M shares outstanding.

Shares Outstanding154.54M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 0.28, and the price-to-book ratio stands at 1.11.

PS Ratio0.28
PB Ratio1.11
P/TBV Ratio-8.77

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 0.68 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 5.90B versus a market cap of 2.48B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.68

Financial Position

As of September 30, 2026, JZJ Chain Drugstore Corporation. Class A maintains a current ratio of 0.71, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 193.51, indicating elevated leverage, while an interest coverage ratio of -0.86 demonstrates limited ability to service its debt obligations.

Current Ratio0.71
Quick Ratio0.15
Debt / Equity193.51
Debt / EBITDA-42.97
Interest Coverage-0.86

Financial Efficiency

CNY

These figures cover the twelve months ended September 30, 2026. The company generates approximately 523,164.41 in revenue per employee across its workforce of 16,536.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee523,164.41
Employee Count16,536.00

Taxes

CNY

Over the twelve months ended September 30, 2026, JZJ Chain Drugstore Corporation. Class A recorded 11.91M in income tax expense. The company reported a pretax loss of -199.45M and -211.26M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax11.91M

Stock Price Statistics

CNY

As of the close on November 17, 2026, JZJ Chain Drugstore Corporation. Class A's stock has declined approximately 39.10% over the past 52 weeks. The 50-day moving average sits at 15.20, while the 200-day moving average is 17.49.

52-Week Price Change-39.10%
50-Day Moving Average15.20
200-Day Moving Average17.49

Income Statement

CNY

Over the twelve months ended September 30, 2026, JZJ Chain Drugstore Corporation. Class A generated 8.65B in revenue and converted that into -211.26M in net income, yielding earnings per share of -1.42. EBITDA reached -100.15M, while operating income came in at 79.05M.

Revenue8.65B
Gross Profit2.96B
Operating Income79.05M
Pretax Income-199.45M
Net Income-211.26M
EBITDA-100.15M
EBIT-100.15M
Earnings Per Share (EPS)-1.42

Balance Sheet

CNY

As of September 30, 2026, JZJ Chain Drugstore Corporation. Class A holds 883.86M in cash and equivalents against 4.30B in total debt, resulting in a net debt position of 2.14B. Total book value stands at 2.23B, with working capital of -1.75B providing operational flexibility.

Cash & Cash Equivalents883.86M
Total Debt4.30B
Net Debt2.14B
Equity (Book Value)2.23B
Book Value Per Share14.40
Working Capital-1.75B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-76.23M

Margins

Over the twelve months ended September 30, 2026, JZJ Chain Drugstore Corporation. Class A posted a gross margin of 34.26, reflecting its pricing power and cost economics. The operating margin of 0.91 and net profit margin of -2.44 provide insight into operational efficiency.

Gross Margin34.26
Operating Margin0.91
Pretax Margin-2.31
Profit Margin-2.44
EBITDA Margin-1.16

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, JZJ Chain Drugstore Corporation. Class A paid dividends of 1.78 per share. The dividend payout ratio of -125.19 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 36.77, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to JZJ Chain Drugstore Corporation. Class A shareholders.

Dividend Per Share1.78
Payout Ratio-125.19
Shareholder Yield36.77

Stock Splits

JZJ Chain Drugstore Corporation. Class A's most recent stock split took place on June 6, 2024 with a 5:6 split ratio.

Last Split Date6/6/2024
Split Ratio5:6

Scores

As of September 30, 2026, JZJ Chain Drugstore Corporation. Class A has an Altman Z-Score of 1.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.31